Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Aarti Industries (AIL) announced that it has entered into a 10+ year dedicated manufacturing and supply agreement with a leading global speciality chemical company serving diverse industries with a cumulative revenue potential of approximately Rs 1500 crore (about US$150 million) over its contract term.
AIL will set up, commission, and operate a dedicated manufacturing facility in India for a speciality chemical used in high-performance applications, based on the customer's proprietary process technology and a structured financial arrangement to finance CAPEX of less than US$25 million.
The model combines global technology with AIL's process scale-up, engineering, and operating capabilities to provide a critical manufacturing outsourcing solution to global companies. Commercial operations are expected to commence in FY2028–29, subject to applicable approvals.
By localising manufacturing through a dedicated Indian setup, this arrangement will support supply-chain resilience and the customer's growth plans in India. For AIL, the agreement broadens its global customer base, strengthens its strategic manufacturing portfolio and creates a platform to deepen the relationship as the customer's India requirements grow.
Post this allotment, the paid-up equity share capital of the Company and increased to Rs 1,81,37,06,820/- (divided in to 36,27,41,364 equity shares of Rs 5/- each).
Aarti Industries announced the successful commissioning of Phase I of its Zone IV project at Jhagadia, Gujarat, marking an important milestone in the Company's ongoing growth and expansion journey.
Phase I brings together Calcium Chloride, PEDA (2-Phenyl Ethyl Diethyl Aniline) and a part of its Multipurpose Plant (MPP), creating complementary capabilities in downstream integration, diversified end-use applications, and flexible multi-product manufacturing. The platform is designed to support the commercialisation of high-value and niche products, with several products planned from Zone IV expected to be manufactured in India for the first time.
PEDA extends AIL's existing Ethylation platform further downstream, building on the Company's established 2,6-Diethyl Aniline capabilities and strengthening its participation in value-added products catering primarily to agrochemical applications.
The Calcium Chloride facility strengthens AIL's Energy & Additives portfolio, with applications across sectors including oilfield and energy-related markets. The Multipurpose Plant provides a flexible manufacturing platform to scale pilot-validated processes into commercial production across multiple products and advanced chemistries, enabling faster response to evolving customer and market requirements. With Phase I commissioning now completed, AIL's focus will progressively shift towards commercial qualification, customer approvals and disciplined ramp-up of the newly commissioned assets.